Patient Characteristics, MIB Labeling Index, SUVs for 18F-FLT in Liver Lesions and Liver Tissues, and Visual Interpretation of PET Results
| Tumor | Liver | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Patient | Sex | Age (y) | Tumor type | Histology | Grade | MIB proliferation index (%) | Mean SUV | Maximum SUV | Mean SUV | Maximum SUV | PET results |
| 1 | M | 75 | HCC | Yes | 1 | 2–5 | 2.5 | 2.9 | 4.7 | 5.0 | Negative |
| 2 | M | 73 | HCC | Yes | 3 | 10–25 | 11.1 | 14.3 | 4.4 | 4.9 | Positive |
| 3 | M | 53 | HCC | Yes | 3 | 2–5 | 3.8 | 4.5 | 9.0 | 11.0 | Negative |
| 4 | M | 48 | HCC | Yes | 2 | 20 | 7.0 | 8.2 | 7.7 | 8.3 | Positive |
| 5 | M | 64 | HCC | Yes | 2 | 2–10 | 6.5 | 8.5 | 5.5 | 6.9 | Positive |
| 6 | M | 72 | HCC | Yes | 2 | 2–5 | 9.6 | 11.1 | 7.8 | 9.3 | Positive |
| 7 | M | 74 | HCC | Yes | 2 | 2–5 | 8.2 | 8.9 | 8.3 | 9.5 | Negative |
| 8 | M | 73 | CCC | Yes | 2 | 30–50 | 11.1 | 14.3 | 5.0 | 5.8 | Positive |
| 9 | M | 58 | HCC | No | NA | NA | 6.7 | 7.9 | 4.9 | 5.9 | Positive |
| 10 | M | 66 | HCC | Yes | NA | NA | 8.2 | 9.1 | 5.0 | 5.4 | Positive |
| 11 | M | 60 | HCC | No | NA | NA | 6.6 | 8.1 | 5.3 | 6.5 | Positive |
| 12 | M | 70 | HCC | Yes | 2 | 10 | 10.7 | 12.3 | 4.6 | 5.7 | Positive |
| 13 | M | 77 | HCC | Yes | 2 | 1 | 6.4 | 7.3 | 7.2 | 8.8 | Negative |
| 14 | M | 77 | HCC | Yes | 2 | 20 | 7.7 | 9.2 | 5.9 | 6.6 | Positive |
| 15 | M | 67 | CCC | Yes | 2 | NA | 16.8 | 18.8 | 13.5 | 15.6 | Positive |
| 16 | M | 66 | HCC | No | NA | NA | 7.9 | 9.0 | 9.5 | 10.2 | Negative |
| 17 | M | 58 | HCC | Yes | 1 | 30 | 11.1 | 14.3 | 4.8 | 5.9 | Positive |
| 18 | F | 78 | HCC | No | NA | NA | 7.3 | 8.9 | 5.9 | 6.6 | Positive |
NA = not available.